Spectrum Pharmaceuticals, Inc.
SPPINASDAQHealthcare
$1.03
$-0.01(-0.49%)
Market Cap$210377146
P/E Ratio—
52W High$1.57
52W Low$0.32
Spectrum Pharmaceuticals, Inc. (SPPI) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
SPPI · earnings · updated Jun 9, 2026
Latest Earnings
Q3 FY2023Report Date: Aug 10, 2023EPS Actual
-$0.17
Est. -$0.04 · -325.0%
Revenue
—
Est. $0.02B
Fiscal Period
Q3 FY2023
FY ends December
Report Date
Aug 10, 2023
After Market Close
▼ Miss EPS
SPPI reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $6.21B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$6.21B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2024 | May 7, 2024 | — | — | — | — | — | — |
| ◌ Q1 FY2024 | Mar 20, 2024 | — | — | — | — | — | — |
| ◌ Q4 FY2023 | Nov 8, 2023 | -$0.02 | — | — | — | $0.02B | — |
| ▼ Q3 FY2023 | Aug 10, 2023 | -$0.04 | -$0.17 | -325.0% | — | $0.02B | — |
| ▲ Q2 FY2023 | May 9, 2023 | -$0.05 | -$0.02 | +60.0% | $0.02B | $0.01B | +42.9% |
| ▲ Q1 FY2023 | Mar 22, 2023 | -$0.09 | -$0.06 | +33.3% | $0.01B | $0.01B | +13.4% |
| ▲ Q4 FY2022 | Nov 10, 2022 | -$0.15 | -$0.12 | +20.0% | — | — | — |
| ▼ Q3 FY2022 | Aug 11, 2022 | -$0.16 | -$0.17 | -6.3% | $0.00B | — | — |
Q2 FY2024
May 7, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2024
Mar 20, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2023
Nov 8, 2023
EPS Actual
—
EPS Est.
-$0.02
EPS Surpr.
—
Revenue
—
Q3 FY2023
Aug 10, 2023Miss
EPS Actual
-$0.17
EPS Est.
-$0.04
EPS Surpr.
-325.0%
Revenue
—
Q2 FY2023
May 9, 2023Beat
EPS Actual
-$0.02
EPS Est.
-$0.05
EPS Surpr.
+60.0%
Revenue
$0.02B
Q1 FY2023
Mar 22, 2023Beat
EPS Actual
-$0.06
EPS Est.
-$0.09
EPS Surpr.
+33.3%
Revenue
$0.01B
Q4 FY2022
Nov 10, 2022Beat
EPS Actual
-$0.12
EPS Est.
-$0.15
EPS Surpr.
+20.0%
Revenue
—
Q3 FY2022
Aug 11, 2022Miss
EPS Actual
-$0.17
EPS Est.
-$0.16
EPS Surpr.
-6.3%
Revenue
$0.00B
No analyst estimates available for SPPI.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q3 FY2023 | Aug 10, 2023 | -325.0% | $1.03 | — | — |
| ▲ Q2 FY2023 | May 9, 2023 | +60.0% | $1.10 | $1.20 | +9.09% |
| ▲ Q1 FY2023 | Mar 22, 2023 | +33.3% | $0.83 | $0.73 | -11.58% |
| ▲ Q4 FY2022 | Nov 10, 2022 | +20.0% | $0.41 | $0.46 | +13.48% |
| ▼ Q3 FY2022 | Aug 11, 2022 | -6.3% | $1.12 | $1.21 | +8.04% |
| ▲ Q2 FY2022 | May 12, 2022 | +50.0% | $0.73 | $0.75 | +2.40% |
| ▼ Q1 FY2022 | Mar 17, 2022 | -23.8% | $0.77 | $0.85 | +10.35% |
| ▲ Q4 FY2021 | Nov 10, 2021 | +30.0% | $2.11 | $2.04 | -3.32% |
Q3 FY2023—
Report Date
Aug 10, 2023
EPS Beat/Miss
-325.0%
Price Before
$1.03
Price After
—
Q2 FY2023+9.09%
Report Date
May 9, 2023
EPS Beat/Miss
+60.0%
Price Before
$1.10
Price After
$1.20
Q1 FY2023-11.58%
Report Date
Mar 22, 2023
EPS Beat/Miss
+33.3%
Price Before
$0.83
Price After
$0.73
Q4 FY2022+13.48%
Report Date
Nov 10, 2022
EPS Beat/Miss
+20.0%
Price Before
$0.41
Price After
$0.46
Q3 FY2022+8.04%
Report Date
Aug 11, 2022
EPS Beat/Miss
-6.3%
Price Before
$1.12
Price After
$1.21
Q2 FY2022+2.40%
Report Date
May 12, 2022
EPS Beat/Miss
+50.0%
Price Before
$0.73
Price After
$0.75
Q1 FY2022+10.35%
Report Date
Mar 17, 2022
EPS Beat/Miss
-23.8%
Price Before
$0.77
Price After
$0.85
Q4 FY2021-3.32%
Report Date
Nov 10, 2021
EPS Beat/Miss
+30.0%
Price Before
$2.11
Price After
$2.04
Avg Beat Reaction+2.01%
Avg Miss Reaction+9.20%
Beat Rate5 / 8 quarters
Largest Move+13.48% (Q4 FY2022)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: SPPI ends December
Spectrum Pharmaceuticals, Inc. (SPPI) most recently reported earnings on August 10, 2023 for Q3 FY2023, posting EPS of $-0.17 — missing the analyst consensus of $-0.04 by -325.0%. The next SPPI earnings date is expected around September 1, 2026.
Each quarter, investors track SPPI earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. SPPI revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
SPPI's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
SPPI earnings · 5 questionsSpectrum Pharmaceuticals, Inc.'s next earnings report is expected around September 1, 2026. SPPI typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; SPPI historically reports after market close (AMC).
SPPI earnings datewhen is SPPI earningsSPPI next earnings datewhen does SPPI report earningsSPPI earnings calendar
▸ Source: FMP · Spectrum Pharmaceuticals, Inc. SEC filings · US GAAP · Spectrum Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026